Search Results 291-300 of 17296 for Teratogenic

1. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

2. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

   The purpose of this study is to evaluate response, survival, safety, and tolerability of treatment with lenvatinib for patients who have anaplastic thyroid ...

3. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

4. Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer - Mayo Clinic

   ... teratogenic effects of which on the developing fetus and newborn are unknown: * Pregnant persons * Nursing persons * Persons of childbearing potential and ...

5. Minority-inclusive Imaging Biomarker-based End of Therapy Trial for 177Lu-PSMA-617 - Mayo Clinic

   ... teratogenic effects on the developing fetus and newborn are unknown * Persons able to father a child who are unwilling to employ adequate contraception * Co ...

6. Our program - Teleneonatology Program

   Find names of experienced neonatologists who are experts in teleneonatology, providing guidance to the local team using telemedicine to help sick newborns.

7. A Clinical Study To Test If An Investigational Treatment Called BNT326 Is Safe And Potentially Beneficial When Used Alone Or In Combination With Other Investigational Treatments Such As BNT327, For People With Advanced Malignant Tumors - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer.

9. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity - Mayo Clinic

   The purpose of this study is to explore the impact of Setmelanotide on obesity in patients with various specific rare genetic mutations. Participation ...

10. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

    ... teratogenic or abortifacient effects, as is radiation therapy; because there is an unknown but potential risk for adverse events in nursing infants ...